expected weight loss on semaglutide Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity Summary of clinical trials that
Description
The market is not static

July 7th, 2025: Ozempic Litigation Developments: Organ Damage Reports Prompt Renewed Legal and Regulatory Scrutiny Ozempic is under increased scrutiny following new reports of serious side effects affecting the pancreas, kidneys, gallbladder, and other organs

The proportion of patients who experienced at least one MACE was 3.8% (61/1591) for semaglutide tablets14 mg and 4.8% (76/1592) for placebo

But despite their undeniable slimming effects, injections of semaglutide branded as Ozempic and Wegovy have been linked to a catalogue of side effects

With clinician guided support, take the first step toward feeling healthier, more confident, and more in control with AgeMD
